Prices are updated after-hours



nasdaq:PBIO Pressure BioSciences, Inc.

PBIO | $2.35 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-11.3% 1m) (-2.1% 1y) (0.0% 2d) (2.2% 3d) (0.0% 7d) (73.34% volume)
http://www.pressurebiosciences.com
Sec Filling | Patents | 14 employees

Pressure BioSciences, Inc. is engagedin the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. Its products includes high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, reagent kits, and service contracts. The firm offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme and BaroFlex, Strips,The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.

add to today's watch list email alert is off


t-cell   brands  

nasdaq:PRVL Prevail Therapeutics Inc.

PRVL | $23.0 | twitter stocktwits trandingview |
Health Technology

(-0.1% 1m) (116.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
http://www.prevailtherapeutics.com
Sec Filling | Patents | 55 employees

Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.

add to today's watch list email alert is off


gene therapies   neurodegenerative   parkinson   msa  

nasdaq:PROF Profound Medical Corp.

PROF | $11.98 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (3.0% 1m) (-33.4% 1y) (0.0% 2d) (1.8% 3d) (7.4% 7d) (90.64% volume)
http://www.profoundmedical.com
Sec Filling | Patents | 75 employees

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

add to today's watch list email alert is off


magnetic resonance   radiation therapy  

nasdaq:PRQR ProQR Therapeutics N.V.

PRQR | $7.19 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-10.1% 1m) (67.6% 1y) (0.0% 2d) (1.7% 3d) (8.9% 7d) (327.73% volume)
http://www.proqr.com
Sec Filling | Patents | 154 employees

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

add to today's watch list email alert is off


fibrosis   genetic   msa   treatment  

nasdaq:TARA Protara Therapeutics, Inc.

TARA | $6.87 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-8.8% 1m) (-68.7% 1y) (0.0% 2d) (1.8% 3d) (9.2% 7d) (-6.73% volume)
http://www.protaratx.com
Sec Filling | Patents | 12 employees

Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY.

add to today's watch list email alert is off


gastrointestinal   metabolic   treatment  

nasdaq:PTI Proteostasis Therapeutics, Inc.

PTI | $1.11 | twitter stocktwits trandingview |
Health Technology

(0.0% 1m) (-12.6% 1y) (0.0% 3d) (0.0% 7d) (149.87% volume)
http://www.proteostasis.com
Sec Filling | Patents | 44 employees

Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.

add to today's watch list email alert is off


fibrosis   msa  

nasdaq:PLSE Pulse Biosciences, Inc

PLSE | $18.76 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-13.5% 1m) (9.8% 1y) (0.0% 2d) (1.1% 3d) (3.2% 7d) (-50.61% volume)
http://www.pulsebiosciences.com
Sec Filling | Patents | 82 employees

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

add to today's watch list email alert is off


vaccine   t-cell  

nasdaq:PBYI Puma Biotechnology Inc

PBYI | $3.29 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-8.6% 1m) (-69.3% 1y) (0.0% 2d) (6.8% 3d) (10.0% 7d) (-39.27% volume)
http://www.pumabiotechnology.com
Sec Filling | Patents | 269 employees

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

add to today's watch list email alert is off


cancer   treatment  

nasdaq:RAPT RAPT Therapeutics, Inc.

RAPT | $30.89 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-18.8% 1m) (32.4% 1y) (0.0% 2d) (1.7% 3d) (2.8% 7d) (-9.27% volume)
http://www.flxbio.com
Sec Filling | Patents | 67 employees

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

add to today's watch list email alert is off


immunology   msa  

nasdaq:RLAY Relay Therapeutics, Inc.

RLAY | $30.85 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-8.6% 1m) (-39.4% 1y) (0.0% 2d) (4.6% 3d) (9.5% 7d) (-32.1% volume)
http://www.relaytx.com
Sec Filling | Patents | 122 employees

Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

add to today's watch list email alert is off


computational  

nasdaq:RTRX Retrophin, Inc.

RTRX | $ | twitter stocktwits trandingview |
Health Technology

(0% volume)
http://www.retrophin.com
Sec Filling | Patents | 221 employees

Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Drugs
Chenodal (Chenodiol)

add to today's watch list email alert is off




nasdaq:SPNE SeaSpine Holdings Corporation

SPNE | $13.92 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-9.4% 1m) (-15.1% 1y) (0.0% 2d) (0.2% 3d) (7.3% 7d) (-7.06% volume)
http://www.seaspine.com
Sec Filling | Patents | 386 employees

SeaSpine Holdings Corp. is a medical technology company, which engages in the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It products include thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA.

add to today's watch list email alert is off


treatment  

nasdaq:SNCA Seneca Biopharma, Inc.

SNCA | $1.66 | twitter stocktwits trandingview |
Health Technology

(0.0% 1m) (143.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-79.38% volume)
http://www.neuralstem.com
Sec Filling | Patents | 5 employees

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

add to today's watch list email alert is off


stem cell   t-cell   nervous system   msa  

nasdaq:SIBN SI-BONE, Inc.

SIBN | $21.43 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-3.2% 1m) (-20.6% 1y) (0.0% 2d) (1.3% 3d) (13.4% 7d) (-45.59% volume)
http://www.si-bone.com
Sec Filling | Patents | 262 employees

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm’s product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

add to today's watch list email alert is off


bone   treatment  

nasdaq:SLNO Soleno Therapeutics, Inc.

SLNO | $0.61 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-20.0% 1m) (-67.2% 1y) (0.0% 2d) (2.4% 3d) (6.8% 7d) (22.4% volume)
http://www.soleno.life
Sec Filling | Patents | 25 employees

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

add to today's watch list email alert is off


metabolic   treatment  

nasdaq:SLDB Solid Biosciences Inc.

SLDB | $1.87 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-15.4% 1m) (-49.5% 1y) (0.0% 2d) (-4.1% 3d) (10.7% 7d) (219.86% volume)
http://www.solidbio.com
Sec Filling | Patents | 121 employees

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

add to today's watch list email alert is off


gene therapies   dmd   duchenne   treatment  

nasdaq:SOLY Soliton, Inc.

SOLY | $20.16 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-2.8% 1m) (117.5% 1y) (0.0% 2d) (-0.3% 3d) (0.2% 7d) (-51.66% volume)
http://www.soliton.com
Sec Filling | Patents | 10 employees

Soliton, Inc. is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm’s devices generate planar acoustic waves or shock waves in cosmetic surgical procedures, aesthetic surgical procedures, and dermatology procedures for treatments. The company was founded by Walter V. Klemp & Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

add to today's watch list email alert is off


aesthetic   treatment  

nasdaq:SONN Sonnet BioTherapeutics Holdings, Inc.

SONN | $0.5459 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-12.8% 1m) (-80.1% 1y) (0.0% 2d) (5.0% 3d) (13.4% 7d) (-10.94% volume)
http://www.sonnetbio.com
Sec Filling | Patents | 587 employees

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey.

add to today's watch list email alert is off


antibody  

nasdaq:SPEL Spinal Elements Holdings, Inc.

SPEL | $ | twitter stocktwits trandingview |
Health Technology

(0% volume)

Sec Filling | Patents | n/a employees

Spinal Elements Holdings, Inc. is a medical device company. It engages in designing, developing, manufacturing, and marketing of innovative medical devices used in spinal surgical procedures. The company was founded on March 11, 2016 and is headquartered in Carlsbad, CA.

add to today's watch list email alert is off




nasdaq:SBPH Spring Bank Pharmaceuticals, Inc.

SBPH | $ | twitter stocktwits trandingview |
Health Technology

(0% volume)
http://www.springbankpharm.com
Sec Filling | Patents | 30 employees

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

add to today's watch list email alert is off


cancer   glass   treatment  

Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying